Exciva
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $71M
Investors
- 7
About Exciva
Exciva GmbH, headquartered in Heidelberg, Germany, develops innovative therapies addressing neuropsychiatric symptoms of dementia, such as agitation and aggression in Alzheimer's patients, enhancing their quality of life through advanced medical solutions. Founded in 2015 by Anton Bespalov and Rao Vepachedu, Exciva GmbH operates from Heidelberg, Germany. Exciva GmbH specializes in developing innovative therapies targeting neuropsychiatric symptoms associated with dementia, particularly focusing on agitation and aggression in Alzheimer's disease patients. The company's core offerings include a groundbreaking therapy aimed at improving the quality of life for individuals experiencing these symptoms. Extensive research and clinical trials are underway to deliver first-in-class and best-in-class treatment options for dementia patients, caregivers, and families.Exciva GmbH generates revenue through partnerships and collaborations in the healthcare sector, focusing on the development and distribution of its therapies. The company engages in strategic alliances with research institutions and healthcare providers to enhance clinical trials and effectively market its solutions. Revenue streams include direct-to-consumer sales and B2B transactions with healthcare providers and institutions. While specific pricing structures are not publicly detailed, the flagship offerings are expected to align with industry-standard pricing models indicative of their innovative nature.
Who invested in Exciva
7 investors across 2 rounds
See all investors in Exciva
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exciva
Who invested in Exciva?
Exciva has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exciva raised?
Exciva has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Exciva last raise money?
Exciva's most recent round on record is a Series B, in Jul 2025.
What does Exciva do?
Exciva GmbH, headquartered in Heidelberg, Germany, develops innovative therapies addressing neuropsychiatric symptoms of dementia, such as agitation and aggression in Alzheimer's patients, enhancing their quality of life through advanced medical solutions.
Where is Exciva headquartered?
Exciva is headquartered in Heidelberg, Germany.
Which VCs invest in companies like Exciva?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Exciva's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Exciva? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.